Compugen's Q4, FY 2010 Revenues Rise | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Compugen today reported increased revenues for its fourth quarter and fiscal-year 2010 on higher fees and milestones.

The Tel Aviv, Israel-based firm, which has developed in silico drug discovery platforms, reported total revenues of $190,000 for the three-month period ended Dec. 31, 2010, compared to $25,000 for the fourth quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.